Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors LA JOLLA, Calif., June 11, 2013 /PRNewswire/ -- Regulus Therapeutics Inc . (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, ...
June 11, 2013 - PR Newswire via Yahoo! Finance